Thomas Tu - Feb 27, 2023 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Medical Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Stock symbol
NARI
Transactions as of
Feb 27, 2023
Transactions value $
-$562,649
Form type
4
Date filed
3/1/2023, 05:13 PM
Previous filing
Feb 22, 2023
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $4.57K +10K +9.34% $0.46* 117K Feb 27, 2023 Direct F1
transaction NARI Common Stock Sale -$359K -6.35K -5.42% $56.51 111K Feb 27, 2023 Direct F1, F2
transaction NARI Common Stock Sale -$209K -3.65K -3.3% $57.09 107K Feb 27, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Option Options Exercise $0 -10K -6.69% $0.00 140K Feb 27, 2023 Common Stock 10K $0.46 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $56.02 to $57.00 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $57.04 to $57.13 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 The option vested with respect to 25% of the underlying shares on April 23, 2020, and vests with respect to the remaining shares in 36 equal monthly installments thereafter.